Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. (Record no. 18182118)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01976 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515132638.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200901s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1432-0584 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s00277-008-0571-z |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Camera, Andrea |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20090112 |
245 00 - TITLE STATEMENT | |
Title | Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Annals of hematology |
Date of publication, distribution, etc. | Feb 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 151-8 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytarabine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Daunorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infusions, Intravenous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liposomes |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recurrence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Salvage Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stem Cell Transplantation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vidarabine |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rinaldi, Ciro R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Palmieri, Salvatore |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cantore, Nicola |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mele, Giuseppina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mettivier, Vincenzo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Miraglia, Eustachio |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mastrullo, Lucia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grimaldi, Francesco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Luciano, Luigia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Guerriero, Anna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rotoli, Bruno |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ferrara, Felicetto |
773 0# - HOST ITEM ENTRY | |
Title | Annals of hematology |
Related parts | vol. 88 |
-- | no. 2 |
-- | p. 151-8 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s00277-008-0571-z">https://doi.org/10.1007/s00277-008-0571-z</a> |
Public note | Available from publisher's website |
No items available.